This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by McCord, R. S. Articles by Morahan, P. S. Search for Related Content PubMed PubMed Citation Articles by McCord, R. S. Articles by Morahan, P. S.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1976 July; 10(1): 28-33
Copyright © 1976 American Society for Microbiology. All Rights Reserved.

Antiviral Effect of Pyran Against Systemic Infection of Mice with Herpes Simplex Virus Type 2

Department of Microbiology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298

ABSTRACT

The immunomodulator pyran markedly protected 5-week-old mice from lethal intravenous infection with herpes simplex virus type 2. The 50% lethal dose was increased almost 100-fold in pyran-treated mice as compared with controls. Although the protection was not as marked in older mice (10 and 16 weeks old), there was a significant increase in mean survival time. When the pathogenesis of herpesvirus disease was monitored in control and drug-treated mice, the effect of pyran was most evident in the spinal cord, where virus was recovered from 20 of 25 control mice and from only 6 of 25 pyran-treated mice. There was also a significant reduction in the titer of virus present, and virus appeared later in the spinal cord of pyran-treated mice than in control mice. The protective effect of pyran was observed only when the drug was administered 24 h before viral challenge, was seen after both intraperitoneal and intravenous injection, and was not due to direct inactivation of the virus.